D. boral capital served as exclusive placement agent to plus therapeutics, inc. (nasdaq:pstv) in connection with its up to $15.0 million private placement

Houston, tx / access newswire / march 11, 2025 / on march 4th, plus therapeutics, inc. (nasdaq:pstv) (the "company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (cns) cancers, announced the pricing of a private placement with gross proceeds to the company expected to be approximately $15.0 million. "this financing coupled with ongoing grant support strengthens our ability to rapidly advance our cns cancer therapies," said marc h.
pstv Ratings Summary
pstv Quant Ranking